Dani Bancroft, Author at Labiotech.eu

About

Former Editor, now flitting back and forth as a freelancer. Originally from London and studied Zoology at the University of Reading, UK. Previous work includes having written for The Spark University Newspaper and the Wellcome Trust.

Articles by Dani Bancroft

News and Trends 27 Oct 2015

Belgian Biotech Seed Investment to Produce Affordable Vaccines for Developing Countries

The Belgian biomanufacturing company Univercells and the Japanese pharmaceutical company Takeda have signed a strategic partnership agreement. Univercells has closed a €3M equity investment with Takeda Ventures to produce affordable vaccines. Univercells provides single-use cost-efficient bioprocess solutions to lead the next generation in biomanufacturing. Under the terms of the agreement, the two biotechs will launch a […]

October 27, 2015 - 2 minutesmins - By Dani Bancroft

News and Trends 27 Oct 2015

Meet the French Woman who started a Biotech to Save her Daughter from a Rare Disease

Karen Aiach had no background in science or the biotech industry, yet when her daughter Ornella was diagnosed with the super-rare Sanfilippo syndrome this inspired her to co-found and become the CEO of Lysogene, today a clinical-stage biotech based in Paris, France. Now Ornella is participating in the ongoing clinical trials for a new gene […]

October 27, 2015 - 7 minutesmins - By Dani Bancroft

News and Trends 26 Oct 2015

Dementia could bankrupt us all… The Biotech ‘A’ Team comes to the rescue!

The fight against Alzheimer‘s with the World Health Organization and the G8 Dementia Summit rallies a collective of biotech industry specialists also wanting in on the battle front. The latest development in the Dementia Discovery Fund (DDF) includes US Biogen‘s dramatic cuts to redirect $250M into the Neurodegenerative disease venture, and investment into $100M ‘A’ […]

October 26, 2015 - 3 minutesmins - By Dani Bancroft

News and Trends 23 Oct 2015

Novartis Monopolises Immuno-Oncology: Three More Biotechs taken Under its Wing

Novartis, the Swiss Biotech giant, has once again broadened its Immuno-oncology portfolio with the acquisition of US Admune Therapeutics (MA) and forming marketing, commercialization and development partnerships with California’s Xoma and Palobiopharma in Barcelona (Spain). Novartis is a Basel giant in the biotech industry, with their research development programs spanning a broad range of fields […]

October 23, 2015 - 2 minutesmins - By Dani Bancroft

News and Trends 22 Oct 2015

For when it actually is Lupus: New Autoimmune Crisis Drug reaches Human Trials

ArGEN-X from Ghent (BE) and Breda (NL) has initiated its phase I human trials for Auto-immune diseases such as systemic lupus erythmatosus (SLE) – a rare chronic disease which has had little progress in the last 50 years. Here is the story behind SLE… As a rare disease, Dr. House and his fictional diagnostics team […]

October 22, 2015 - 4 minutesmins - By Dani Bancroft

News and Trends 22 Oct 2015

This €200M French Biotech uses Red blood Cells to Fight Leukemia & Pancreatic Cancer

Lyon’s Erytech (France) is a clinical biopharma working on improving its red blood cell transported drug, targeting cancers such as acute lymphocytic leukemia (ALL) and pancreatic adenocarcinoma. Now phase I/II trials for its GRASPA therapy have demonstrated good efficacy and safety. Circulating asparagine is needed by cancer cells to grow and proliferate. Erytech’s platform uses […]

October 22, 2015 - 2 minutesmins - By Dani Bancroft

News and Trends 22 Oct 2015

Aquanos Algae: Israeli Start-up fixes the Global Sustainability issue in Recycling Sewage Water

Aquanos has the solution to expensive and energy intensive waste-water treatment. Having revamped the pre-existing Microalgae technique for sewage remediation to be far more efficient, the Gemini project also generates biomass products and is being trialed on a Northern Israeli kibbutz, with negotiable projections for use in the developing world. Man, we cannot get enough of […]

October 22, 2015 - 4 minutesmins - By Dani Bancroft

News and Trends 21 Oct 2015

CAR-T Wannabe? Immuno-oncology Start-up snowballs $102M for Series A Fund

Gritstone Pharmaceuticals is a US start-up which will focus on R&D of its new CAR-T cancer therapy technique: tumor-specific neo-antigen (TSNA). An impressive financial syndicate is backing its launch this month, having achieved a £102M series A pot for their lung cancer research. This cash is a clear indication that this start-up has the 3 […]

October 21, 2015 - 3 minutesmins - By Dani Bancroft

News and Trends 20 Oct 2015

Scaling-up Biofuels: The Challenges of Giant Bioreactors

Global Bioenergies from France is building a proto-plant for Isobutene production in Germany, with partnerships with car manufacturer Audi. Now their plant will receive a 5,000 Litre fermentation tank, after overcoming the challenging process of scaling-up second generation biofuel production. Global Bioenergies’ return to first generation biofuel production has already been discussed as a bit […]

October 20, 2015 - 3 minutesmins - By Dani Bancroft

News and Trends 19 Oct 2015

Synbio Perfumery: Making Smells and Flavors with Microbes

Isobionics is a biotech from the Netherlands that specializes in synthetic bio-production of natural essential oils and flavorings for use in the food, perfume and detergent industry. On the other hand, Evolva, from Basel, are estimated to produce up to $500M worth of synthetic vanilla essence for the industry each year. Using bacteria and yeast […]

October 19, 2015 - 4 minutesmins - By Dani Bancroft

News and Trends 16 Oct 2015

Bavarian Facility can now grow Global Strains of Algae for Aerospace Biofuel Production

The Technology University of Munich (TU München) has built a unique global-climate simulating Algal plant on the Ludwig Bölkow Campus in Ottobrunn (Bavaria). Able to cultivate algal strains from all over the world, the research team hopes this will allow them to study and discover new types to be exploited by Biotechs for biofuel production, […]

October 16, 2015 - 3 minutesmins - By Dani Bancroft

News and Trends 15 Oct 2015

Ablynx richly rewarded for MSD’s Nanobody Proof in Immuno-Oncology

Ablynx – the Belgian nanobody biotech (which uses monoclonal antibodies of Alpacas), has now achieved it’s first pre-clinical milestone in its immuno-oncology partnership with MSD (Merck & Co). Now Ablynx has achieved proof of concept for one of the 17 Nanobodies being studied. Ablynx has therefore received the first €3.5M in milestone payments from MSD […]

October 15, 2015 - 2 minutesmins - By Dani Bancroft

Knowledge hub

Categories

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Approaches

Therapeutic areas

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Dani Bancroft

About

Articles by Dani Bancroft

Belgian Biotech Seed Investment to Produce Affordable Vaccines for Developing Countries

Meet the French Woman who started a Biotech to Save her Daughter from a Rare Disease

Dementia could bankrupt us all… The Biotech ‘A’ Team comes to the rescue!

Novartis Monopolises Immuno-Oncology: Three More Biotechs taken Under its Wing

For when it actually is Lupus: New Autoimmune Crisis Drug reaches Human Trials

This €200M French Biotech uses Red blood Cells to Fight Leukemia & Pancreatic Cancer

Aquanos Algae: Israeli Start-up fixes the Global Sustainability issue in Recycling Sewage Water

CAR-T Wannabe? Immuno-oncology Start-up snowballs $102M for Series A Fund

Scaling-up Biofuels: The Challenges of Giant Bioreactors

Synbio Perfumery: Making Smells and Flavors with Microbes

Bavarian Facility can now grow Global Strains of Algae for Aerospace Biofuel Production

Ablynx richly rewarded for MSD’s Nanobody Proof in Immuno-Oncology

Subscribe to our newsletter to get the latest biotech news!

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

About

Articles by Dani Bancroft

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!